Jacqueline A. DeJournett

Associate

Atlanta + 1.404.581.8347

Connect:

Share

Jacqueline DeJournett's practice focuses on all aspects of privacy and cybersecurity matters, including compliance, corporate transactions, incident response, and investigations.

Jacqueline provides clients with strategic advise on compliance with state, federal, and global privacy laws, including the General Data Protection Regulation (GDPR), California Consumer Privacy Act (CCPA), California Privacy Rights Act (CPRA), Virginia Consumer Data Protection Act (VCDPA), Colorado Privacy Act (CPA), Connecticut Data Privacy Act (CTDPA), Utah Consumer Privacy Act (UCPA), Gramm-Leach-Bliley Act (GLBA), Children's Online Privacy Protection Act (COPPA), Illinois Biometric Information Privacy Act (BIPA), the Federal Trade Commission (FTC) Act, and other U.S. consumer privacy statutes. In particular, Jacqueline has significant experience designing and helping clients implement data privacy law compliance programs, including advising on data mapping, data subject request processes, internal and external-facing privacy and security policies, and cross-border data transfer mechanisms.

Jacqueline also represents clients in domestic and cross-border corporate transactions, counseling on cybersecurity and privacy matters, including due diligence and transitional arrangements. Jacqueline's experience includes negotiating data processing agreements and privacy and data security provisions in processor agreements. Jacqueline also handles all aspects of U.S. and international data breach investigation and response, including advising clients on forensic investigations, notification, and other legal obligations. Her experience includes representing clients under investigation by the FTC and other regulatory and government authorities.

Jacqueline maintains an active pro bono practice. Through the Firm's Border Project, she has helped represent individuals seeking asylum following persecution in their home countries. She is also part of the Firm's initiative to combat human trafficking.

Experience

  • Parker acquires Curtis InstrumentsJones Day is advising Parker Hannifin Corporation in the approximately $1 billion acquisition of Curtis Instruments, Inc. from Rehlko (f/k/a Kohler Energy), a Platinum Equity portfolio company.
  • Kraken acquires NinjaTraderJones Day advised Payward, Inc. d/b/a Kraken, a cryptocurrency exchange, in connection with its $1.5 billion acquisition of NinjaTrader Group Holdings, LLC, a leading futures trading broker.
  • VSE Corporation sells its Wheeler Fleet Solutions businessJones Day advised VSE Corporation (NASDAQ: VSEC), a leading provider of aftermarket distribution and repair services, in the sale of its Fleet business segment, Wheeler Fleet Solutions, Co., to One Equity Partners for up to $230 million in total consideration.
  • Artis BioSolutions acquires Landmark BioJones Day advised Artis BioSolutions, a newly launched company dedicated to streamlining the discovery, process development, and manufacturing of genetic medicines, in its acquisition of Landmark Bio, allowing expansion of manufacturing and commercialization of advanced therapies.
  • Flowers Foods acquires Simple MillsJones Day advised Flowers Foods, Inc. in the $795 million acquisition of Simple Mills, Inc., a leading provider of gluten-free baking mixes, crackers, cookies, and snack bars made with almond and veggie flours.
  • ETS acquires PSIJones Day advised Educational Testing Service (ETS) in its acquisition of PSI Services LLC, a global leader in test development and delivery across workforce certification and licensure.
  • SingTel sells Trustwave to The Chertoff GroupJones Day represented Singapore Telecommunications Limited, southeast Asia’s largest telecommunications company, in the sale of Trustwave, a cyber security and managed security services business, to funds affiliated with The Chertoff Group for $205 million. In connection with the sale of Trustwave, Jones Day represented SingTel, as lender, in connection with a unique $195 million senior secured term loan and $40 million unsecured multiple draw term loan facility provided to Trustwave.
  • Asbury Automotive Group acquires Jim Koons AutomotiveJones Day advised Asbury Automotive Group, Inc. (NYSE: ABG), one of the largest automotive retail and service companies in the U.S., in its acquisition of Jim Koons Automotive Group of Companies for approximately $1.2 billion in cash.
  • EagleTree Capital acquires Summit Hill FoodsJones Day advised EagleTree Capital in the acquisition and financing of Summit Hill Foods, Inc., a leading branded food company producing nationally recognized, premium brands, including Better Than Bouillon and The Original Louisiana Hot Sauce.
  • Riverside portfolio company acquires Miracle MethodJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Threshold Brands of Miracle Method, the leading franchised provider of bath and kitchen refinishing services in the United States.
  • Affiliate of Centre Lane Partners acquires appliance business from Instant BrandsJones Day advised an affiliate of Centre Lane Partners in the acquisition and financing of the appliances business of Instant Brands, designer and distributor of kitchen and home appliances, including the Instant Pot, pursuant to Section 363 of title 11 of the United States Code.
  • FLEETCOR acquires PayByPhoneJones Day advised FLEETCOR Technologies, Inc. in the acquisition of PayByPhone, a global provider of digital parking payment solutions.
  • restor3d acquires Conformis, Inc.Jones Day advised restor3d, Inc., a leading personalized 3D-printed orthopedic company, on its acquisition of Conformis, Inc. (NASDAQ: CFMS), a leading medical technology company focused on orthopedic patient care.
  • Five9 acquires Aceyus for $82 millionJones Day represented Five9, Inc. in its acquisition of 100% of the equity of Aceyus, Inc. for $82 million in cash.
  • Astellas acquires Iveric bioJones Day advised Astellas Pharma Inc. in the $5.9 billion cash acquisition of Iveric bio, Inc., a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
  • Fortrea completes $570 million private placement of Senior Secured Notes and obtains $1.5 billion credit facilityJones Day represented Fortrea Holdings Inc., a leading global contract research organization (“CRO”) that provides comprehensive phase I through IV biopharmaceutical product and medical device services, patient access solutions and other enabling services, in connection with the Rule 144A and Regulation S offering of $570 million aggregate principal amount of 7.500% Senior Secured Notes due 2030 and a $1.5 billion senior secured credit facility as part of its spin-off from Laboratory Corporation of America Holdings.
  • Hard Rock Digital enters partnership with Playtech plcJones Day advised Hard Rock Digital in connection with its strategic partnership with Playtech plc.
  • Human trafficking survivor obtains vacatur reliefJones Day's Post-Conviction Relief Program obtained vacatur and records restriction of convictions for Client C.
  • EagleTree Capital portfolio company acquires LauchlanJones Day advised EagleTree Capital in the acquisition by portfolio company The Channel Company, a global provider of news, insights, strategy, events, and marketing services for the technology industry, of Lauchlan, a U.S. based global marketing agency dedicated to the technology industry.
  • Infobase receives majority investment from Northlane Capital PartnersJones Day represented Centre Lane Partners, LLC in connection with the majority investment from Northlane Capital Partners in Infobase.
    • View All

    October 2023 White Paper

    Considerations for Addressing DOJ's Corporate Compliance Guidance on Mobile Devices and Messaging Platforms

    April 2023 Alert

    Iowa Becomes Sixth State to Enact a Comprehensive Data Privacy Law

    October 2021 Alert

    Department of Commerce Seeks Comment on Regulation of IaaS Providers

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.